July 2, 2025
INNOptimizer is using latest Bayesian Optimization algorithms and a broad set of analytical tools to guide optimizations with minimum experimentation needed. Don't waste time and money with poor experimental design - use INNOptimizer™ to guide your experiments with state-of-the art Bayesian Optimization algorythms.”— Oliver May (GM Synsilico)GELEEN, LIMBURG, NETHERLANDS, July 2, 2025 /EINPresswire.com/ -- SynSilico, [...]
Sartorius completes acquisition of MatTek
July 2, 2025
The life science group Sartorius has successfully closed the acquisition of MatTek Corp, including Visikol Inc, from the Swedish BICO Group AB, as announced in April. The acquisition was completed on July 1, 2025, following the receipt of the required regulatory approval and the fulfillment of other customary closing conditions. With the integration of the [...]
Wabtec Finalizes Acquisition of Evident’s Inspection Technologies Division
July 1, 2025
PITTSBURGH – Wabtec Corporation (NYSE: WAB) announced today that it completed the acquisition of Evident’s Inspection Technologies division (Inspection Technologies), formerly part of the Scientific Solutions Division of Olympus Corporation, a global leader in Non-Destructive Testing, Remote Visual Inspection and Analytical Instruments solutions for mission critical assets. This acquisition strengthens Wabtec’s Digital Intelligence business with [...]
LICORbio Expands Portfolio with Strategic Acquisition of SERVA Electrophoresis
July 1, 2025
LINCOLN, NE and Heidelberg, Germany – LICORbio, a leading innovator in life science imaging and analytical solutions, today announced the acquisition of SERVA Electrophoresis, a privately held company known for its high-quality electrophoresis reagents, consumables, and workflow instrumentation. The transaction strengthens LICORbio’s position as a comprehensive solutions provider in protein analysis and enhances its commitment to [...]
Imagene AI Hits $45M in Total Funding After Completing $23M Series B Led by Larry Ellison
July 1, 2025
Imagene AI delivers a living intelligence engine for adaptive, insight-driven precision medicine. MIAMI, - Imagene AI, a pioneer in multi‑modal foundation models for precision medicine, today announced the successful close of a $23 million Series B financing round led by Oracle Chairman and CTO Larry Ellison. This latest infusion brings Imagene AI's total capital raised [...]
BICO has completed the divestment of MatTek and Visikol
July 1, 2025
ICO has as of today completed the divestment of MatTek and Visikol to Sartorius, for USD 80m on a cash and debt-free basis, after customary regulatory approval has been obtained. Following transaction costs, net debt and working capital adjustments net proceeds are estimated to amount to USD 77.2m. The divestment follows the Group’s updated strategy [...]
July 1, 2025
Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market Cambridge, UK – 4basebio PLC (AIM: 4BB) (“4basebio”), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field. [...]
July 1, 2025
Saint-Germain-en-Laye, France – Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and bioanalytical products. Under this agreement, Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the United Kingdom. MN’s Bioanalysis [...]
July 1, 2025
SPECTRO Analytical Instruments has unveiled its new SPECTROGREEN MS Quadrupole Mass Spectrometer, an innovative ICP-MS solution engineered for high-performance, routine trace-level elemental analysis with unmatched ease of use. The SPECTROGREEN MS combines state-of-the-art technology with simplified workflows to address the needs of laboratories handling environmental, pharmaceutical, food, consumer product testing, and industrial applications. Highlights of [...]
July 1, 2025
Genovis AB (publ) (“Genovis”) today announces that it has exercised its call option to acquire the remaining 75% of SEQURNA AB (“SEQURNA” or “Company”), a strategic move that accelerates Genovis’ expansion into the fast-growing genomics sector. This acquisition unlocks new product offerings for Genovis to both existing and new customers and further paves the way [...]